Abstract

The present disclosure relates to an amorphous solid dispersions comprising Obicetrapib hemi calcium, which represented by the following structural formula-1a and one or more pharmaceutically acceptable excipients and processes for preparation thereof.

Formula-1a

The present disclosure also relates to novel salts of Obicetrapib and process for the preparation thereof.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS